NCT07619209 The Effect of Progressive Muscle Relaxation and Deep Breathing Exercises Applied to Palliative Care Cancer Patients on Dyspnea, Fatigue, and Self-Care Behaviors
| NCT ID | NCT07619209 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-01-01 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the effects of Progressive Muscle Relaxation (PMR) exercises and deep breathing exercises on dyspnea, fatigue, and self-care behaviors among cancer patients receiving palliative care. Advanced-stage cancer patients frequently experience debilitating symptoms such as shortness of breath (dyspnea) and severe fatigue, which significantly impair their functional capacity and daily self-care activities. Participants in this study will be assigned to either a progressive muscle relaxation intervention group or a structured deep breathing exercise group. The study aims to determine whether these non-pharmacological relaxation techniques can effectively reduce the severity of dyspnea and fatigue, thereby improving the patients' overall self-care behaviors and physical comfort in a palliative care setting.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older Being literate (able to read and write) Having no significant hearing or visual impairment that prevents communication or cooperation Receiving treatment in the palliative care unit Having a confirmed medical diagnosis of cancer Having a Glasgow Coma Scale (GCS) score of 10 or higher Being able to communicate via telephone and SMS for post-discharge follow-up Having a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 3 or below Having an ECOG Performance Status Scale score of 3 or below Having a Hemoglobin (Hb) value of 8 gm/dL or higher Volunteering to participate in the study and providing informed consent Exclusion Criteria: * Currently practicing or having recently practiced Progressive Muscle Relaxation (PMR) or deep breathing exercises actively Having a primary respiratory system disease diagnosis (such as COPD, asthma, or pneumonia) Having a medical diagnosis of dementia, agitation, or delirium Receiving Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BiPAP) support Being on active antipsychotic or sedative medical treatment Having a Common Terminology Criteria for Adverse Events (CTCAE) Dyspnea Classification of Grade 4 or higher
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07619209 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07619209 currently recruiting?
Yes, NCT07619209 is actively recruiting participants. Contact the research team at aslihan.kulcu@gmail.com for enrollment information.
Where is the NCT07619209 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye), Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07619209 clinical trial?
NCT07619209 is sponsored by Ankara University. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.